| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.44B | +2.1% |
| Cost of Revenue | $1.86B | +8.3% |
| Gross Profit | $1.58B | -4.4% |
| R&D Expense | $395.2M | +5.0% |
| SG&A Expense | $946.5M | +5.9% |
| Operating Income | $68.2M | -73.1% |
| Pre-tax Income | $22.0M | -89.4% |
| Income Tax | $29.3M | -67.9% |
| Net Income | -$8.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $298.8M | +62.9% |
| Accounts Receivable | $544.9M | -3.6% |
| Inventory | $1.09B | +2.5% |
| Current Assets | $2.21B | +7.8% |
| Total Assets | $6.24B | +7.5% |
| Current Liabilities | $1.28B | -0.2% |
| Long-term Debt | $1.87B | -10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $134.1M | -46.6% |
| Capital Expenditures | $90.8M | -21.2% |
| Investing Cash Flow | -$196.5M | +88.8% |
| Financing Cash Flow | $135.1M | -89.0% |
| Free Cash Flow | $43.3M | -68.2% |
| -107.6% |
| EPS (Basic) | -$0.15 | -119.7% |
| EPS (Diluted) | -$0.15 | -119.7% |
| Total Liabilities |
| $3.73B |
| -6.5% |
| Stockholders' Equity | $2.46B | +37.9% |